ArticleTurkish journal of medical sciences2025

Relcovaptan: a promising therapeutic agent in traumatic spinal cord injury that acts by modulating newly identified transcriptional regulators of aquaporins compared to tolvaptan.

Şeyma Iş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.